Prevalence and Socio-Demographics of Hepatitis B Surface Antiginaemia among Secondary school Children in an urban community Southeast Nigeria: A Cross sectional study
Prevalence and Socio-Demographics of Hepatitis B Surface Antiginaemia
Keywords:Prevalence, Endemicity, Hepatitis B Virus (HBV), Sociodemographics
Background: Hepatitis B virus (HBV) is responsible for a prevalent infectious disease in the world which is of public health importance due to its risk of chronicity with attendant high morbidity and mortality. Although it is a vaccine preventable disease, Nigeria is still highly endemic for HBV. The aim of the study was to determine the seroprevalence of Hepatitis B surface antigenemia and sociodemographic characteristics among secondary school students in Onitsha.
Methods: This is a cross sectional descriptive study of Hepatitis B surface antigenemia in secondary schools’ students in Onitsha, South-East Nigeria. Participants were recruited using a multi-staged sampling technique and their HBsAg status was determined using MonalisaTM HBsAg Ultra ELISA kit.
Results: Out of the 751 students assessed, 57 were sero-positive to HBsAg giving a prevalence of 7.6%. The prevalence was more in males than females and students in the higher socioeconomic class were least affected. The highest prevalence was observed among students within the age group of 14-16years. Only 4.3% of the students had received HBV vaccine.
Conclusion: The endemicity of Hepatitis B in the study population calls for urgent action. This is because the infected students can be reservoirs for horizontal transmission. Furthermore, asymptomatic HBV infection can progress to chronic complications like liver cirrhosis and hepatocellular carcinoma. Therefore, the introduction of vaccination of adolescents against HBV in the school health program will be an effective way of controlling the high prevalence of HBV infection in this population.
Bamdad T, Yari A. Hepatitis Viruses, Encyclopedia of infection and immunity. Elsevier, 2022:113-122. https://doi.org/10.1016/B978-0-12-818731-9.00078-1.
World Health Organisation. Hepatitis B facts sheet. July 2021. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386 (10003):1546–55.
Thio CL, Hawkins C. 148 - Hepatitis B Virus and Hepatitis Delta Virus. In: Bennett JE, Dolin R, Blaser MJ, (eds). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (8th Edition), W.B. Saunders, 2015, Pg 1815-1839.e7, ISBN 9781455748013
Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. World Health Organization, Geneva 2016 apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf
Ajuwon BI., Yujuico I, Roper K, Richardson A, Sheel M, Lidbury BA. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infect Dis. 2021;21:1120. https://doi.org/10.1186/s12879-021-06800-6
Ikobah J, Okpara H, Elemi I, Ogarepe Y, Udoh E, Ekanem E. The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme on Immunization schedule. Pan Afr Med J. 2016;23:128. Published 2016 Mar 25. doi:10.11604/pamj.2016.23.128.8756
Ugwuja E, Ugwu NC. Seroprevalence of Hepatitis B Surface Antigen and Liver Function Test among Adolescents in Abakaliki, South Easthern Nigeria. Int J Trop Med. 2010;6:1–6.
Bukbuk DN, Bassai AP, Mngoro ZM. Seroprevalence of Hepatitis B surface antigen among primary school pupils in rural Hawal valley, Borno State, Nigeria. J Com Med Prim Heal Care. 2005;17:20–3.
Chukwuka JO, Ezechukwu CC, Egbuonu I, Okoli CC. Prevalence of Hepatitis B surface antigen in Primary school children in Nnewi, Nigeria. Niger J Clin Pr. 2004;7:8–10.
Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku B, Aderinola M, et al. Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. Am J Trop Med Hyg. 2016;95(4):902-907. doi:10.4269/ajtmh.15-0874
Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis. Niger J Clin Pract 2015;18:163-72
Organization WH. Report of the fourteenth meeting of the Global Advisory Group of the Expanded Programme on Immunization. Wkly Epidemiol Rec. 1992;3:11–5.
GAVI. Nigeria Launches Pentavalent Vaccine. 2015.
Nigeria: WHO and UNICEF estimates of immunization coverage: 2020 revision https://www.who.int/publications/m/item/immunization-nga-2021-country-profile
Britannica, The Editors of Encyclopaedia. "Onitsha". Encyclopedia Britannica, 8 Jul. 2019, https://www.britannica.com/place/Onitsha-Nigeria. Accessed 17 May 2022.
Mann PS. Introductory statistics: Using Technology. 10th Edition. USA: John Wiley and Sons; 2020.
Oyedeji GA. Socio-economic and cultural background of hospitalized children in Ilesha. Niger J Paediatr. 1985;12:111–7.
Adetunji SO, Ajite A, Adetunji BI, Olaniran OB, Donbraye E. Hepatitis B virus infection among Nigerian pediatric population. J Immunoassay Immunochem. 2021 Mar 4;42(2):121-128. doi: 10.1080/15321819.2020.1833918. Epub 2020 Oct 25. PMID: 33103551.
Mathew M, Tinuola FR, Goel SR, Taiwo O, Philip J. Prevalence of Hepatitis B among School Adolescents in Jos, Plateau State Nigeria. Texila Int J Public Health. 2018;6(4) doi: 10.21522/TIJPH.2013.06.04.Art006
Isa MA, Bello HS, Mustapha A, Mangga HA, Gulani IA, Aisha MA. Prevalence of hepatitis B Virus among students attending University of Maiduguri clinic, Borno, Nigeria. Int. J. Adv. Res. Biol.Sci. 2015; 2(1):138–142.
Aminu M, Okachi EE, Abubakar SM, Yahaya A. Prevalence of hepatitis B virus surface antigen among healthy asymptomatic students in a Nigerian University. Ann Afr Med 2013;12:55-6. doi: 10.4103/1596-3519.108257
Ndako JA, Nwankiti OO, Echeonwu GO, Junaid SA, Anaele O and Anthony TJ. Studies on Prevalence and risk Factors for Hepatitis B surface Atigen among Secondary School Students in North-central Nigeria. Sierra Leone J Biomed Res. 2011;3(3):163–8.
Eke CB, Ogbodo SO, Ukoha OM, Ibekwe RC, Asinobi IN, Ikefuna AN, et al. Seroprevalence and Risk Factors of Hepatitis B Virus Infection among Adolescents in Enugu, Nigeria. J Trop Pediatr. 2015;61(6):407-13. doi: 10.1093/tropej/fmv035. Epub 2015 Sep 27. PMID: 26411561.
Nworie O, Orji O, Jerry UO, Ekuma UO, Ukpabi NN, Onu EN. Studies on the Seroprevalence of Hapetitis B Virus Infection among School Children in Ohaukwu, Ebonyi State, Nigeria. World Applied Sciences Journal 2015; 33 (11): 1767-1772. doi: 10.5829/idosi.wasj.2015.33.11.15626
Sadoh AE, Ofili A. Hepatitis B infection among Nigerian children admitted to a children's emergency room. Afr Health Sci. 2014;14(2):377-83. doi: 10.4314/ahs.v14i2.13. PMID: 25320587; PMCID: PMC4196419.
Abesig J, Chen Y, Wang H, Sompo FM, Wu IX. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLoS One. 2020; 15(6): e0234348. doi: 10.1371/journal.pone.0234348
Atakli A, Sarfo B. Factors associated with hepatitis-B virus infection among students in Krachi senior high school in the Krachi West district of the Volta region. J Viral Hepat. 2018; 25(S2): 104-6. doi: 10.1111/jvh.123_12923.
Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Noumegni SRN, Ngo-Malabo ET, et al. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open. 2017;7(6):e015298. doi: 10.1136/bmjopen-2016-015298. PMID: 28667212; PMCID: PMC5734365.
Yendewa GA, Lakoh S, Yendewa SA, Bangura K, Lawrence H, Patiño L, et al. Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: a cross-sectional study. Int J Infect Dis. 2021;102:45–52. https://doi.org/10.1016/j.ijid.2020.09.1459
Damien, B, Aguemon B, Degbey C, Agbazahou S, Padonou S, Ouendo, M. Seroprevalence of Hepatitis B Virus Infection and Risk Factors among Adolescents and Youth in Secondary School in 2018, Commune of Covè, Benin. Open J Epidemiol. 2021;11:326-347. doi: 10.4236/ojepi.2021.113028.
Argaw, B, Mihret A, Aseffa A. Tarakegne A, Hussen S, Wachamo D et al. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia. BMC Infect Dis 2020;20:528 https://doi.org/10.1186/s12879-020-05229-7
López-Gatell H, García-García L, Echániz-Avilés G, Cruz-Hervert P, Olamendi-Portugal M, Castañeda-Desales D (2019). Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results. Human vaccines & immunotherapeutics 2019;15(2):433–439. https://doi.org/10.1080/21645515.2018.1533617
Prabdial-Sing N, Makhathini L, Smit SB, Manamela MJ, Motaze NV, Cohen C, et al. Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance. PLoS ONE. 2019;14(5): e0217415. https://doi.org/10.1371/journal.pone.0217415
Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR. Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016. Clin Infect Dis. 2019;69(4):709-712. doi:10.1093/cid/ciz001
European Centre for Disease Prevention and Control. Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC; 2016.
Tadongfack TD, Keubo F, Bianke P. (2020). Hepatitis B infection in the rural area of Dschang, Cameroon: seroprevalence and associated factors. The Pan Afr. Med. J. 2020;36:362. https://doi.org/10.11604/pamj.2020.36.362.17787
Xu Y, Liu H, Wang Y, Hao R, Li Z, Song H. The next step in controlling HBV in China. BMJ 2013;347:f4503. doi: 10.1136/bmj.f4503.
Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. The Lancet Gastroenterology & Hepatology 2017;2(12):900-909. doi:https://doi.org/10.1016/S2468-1253(17)30295-9
McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009;49(5):S45–55. doi: 10.1002/hep.22898. PMID: 19399792.
Anigilaje EA, Olutola A. Prevalence and Clinical and Immunoviralogical Profile of Human Immunodeficiency Virus-Hepatitis B Coinfection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria. ISRN Pediatr 2013;2013:932697. doi: 10.1155/2013/932697.
How to Cite
Copyright (c) 2022 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to firstname.lastname@example.org.